ERBB2 and neoplasm: In breast cancer, the expression of SNCG was observed to be closely correlated with the disease stage, lymph node involvement, metastasis, tumor size and Her-2 status, but not with estrogen receptor (ER) and progesterone (PR) expression status (23).